AI Tools for Designing Cell-Penetrating Peptides: A Comprehensive Guide to What's Available | Research

The takeaway

A systematic review catalogs the growing landscape of AI and bioinformatics tools that predict which peptides can cross cell membranes for drug delivery applications.

15 years of AI tools cataloged
The review covers computational tools from 2011–2025 that predict cell-penetrating ability, providing researchers a comprehensive guide to the available options

What the researchers found

AI and bioinformatics tools have dramatically accelerated the discovery and design of cell-penetrating peptides (CPPs). This systematic review covers computational tools developed between 2011 and 2025 that predict whether a peptide can cross cell membranes. These tools use various machine learning and AI algorithms to analyze peptide sequences and predict their cell-penetrating potential, replacing slow and expensive trial-and-error laboratory screening.

The review catalogs the landscape of available prediction tools, their underlying algorithms, strengths, and limitations. CPPs can deliver therapeutic cargo including small molecule drugs, proteins, and nucleic acids into cells, making them valuable for drug delivery, gene therapy, and molecular imaging. AI-driven design is enabling researchers to identify novel CPPs faster than ever before.

Why it matters

Finding peptides that can reliably cross cell membranes has traditionally required extensive laboratory testing. AI prediction tools are transforming this process, potentially identifying effective CPPs from sequence data alone in minutes rather than months. This review provides researchers with a practical guide to choosing the right computational tools for their CPP design projects, which could accelerate the development of peptide-based drug delivery systems for cancer therapy, gene therapy, and other applications.

The numbers in context

Literature from 2011–October 2025 · 4 databases searched (PubMed, Embase, Scopus, Web of Science) · Multiple AI/ML algorithms reviewed · Applications: drug delivery, gene therapy, molecular imaging

How the study worked

The authors conducted a systematic literature search across PubMed, Embase, Scopus, and Web of Science covering publications from 2011 to October 2025. They identified and reviewed bioinformatics tools and AI algorithms designed for peptide prediction, with particular focus on those predicting cell-penetrating potential. The review catalogs tool capabilities, algorithmic approaches, and practical applications.

Who was studied

Review article — systematic survey of computational tools and literature

What this study cannot tell us

As a review, no new computational tools or experimental data are presented. The field is evolving rapidly, so tools published after October 2025 are not covered. Most AI prediction tools have been validated on limited datasets and may not generalize to all peptide types. The review does not provide head-to-head performance comparisons between tools on standardized benchmarks. Predicted cell-penetrating ability does not guarantee successful drug delivery in living systems.

How to read the evidence

This is a systematic review in a respected drug delivery journal, providing a comprehensive survey of the field. While it does not generate new data or tools, it organizes and evaluates the existing landscape of computational resources, which is valuable for researchers navigating a rapidly growing field.

When this study was published

Published in 2026 in Expert Opinion on Drug Delivery. This is an extremely current review capturing the latest AI/bioinformatics developments through October 2025.

The bigger picture

The intersection of AI and peptide science is one of the most dynamic areas in drug delivery. As AI tools become more accurate at predicting cell-penetrating ability, the traditional bottleneck of CPP discovery — extensive laboratory screening — may largely be replaced by computational design. This could unlock a wave of new peptide-based therapeutics that can deliver drugs to previously inaccessible intracellular targets, transforming treatment for cancer, genetic diseases, and neurological conditions.

Questions still open

How accurate are current AI prediction tools for CPPs compared to experimental validation — what's the false positive rate?
Can AI tools predict not just membrane penetration but also cargo delivery efficiency and toxicity simultaneously?
Will generative AI models eventually design entirely novel CPP sequences optimized for specific therapeutic applications?

Common questions

What are cell-penetrating peptides used for?

Cell-penetrating peptides (CPPs) are short protein fragments that can cross cell membranes, carrying therapeutic cargo inside. They're being developed to deliver cancer drugs directly into tumor cells, transport gene therapy materials, and carry imaging agents for diagnostics. Their ability to bypass the cell membrane — normally a major barrier to drug delivery — makes them one of the most promising tools in modern pharmaceutical science.

How does AI help find new cell-penetrating peptides?

AI algorithms learn patterns from databases of known cell-penetrating peptides — what amino acid sequences, charges, and structures enable membrane crossing. They can then screen millions of candidate peptides computationally and predict which ones are most likely to penetrate cells. This is vastly faster and cheaper than testing each peptide in the lab, potentially reducing discovery timelines from years to days.

Read the original research

Emerging landscape of bioinformatics and artificial intelligence applications in cell-penetrating peptide-based delivery.

Expert opinion on drug delivery, 23(3), 495-515

View on PubMed ↗Publisher’s paper ↗

Citation

Sun, Yu; Zhang, Muqing; Liu, Huiting; Wang, Hu. (2026). Emerging landscape of bioinformatics and artificial intelligence applications in cell-penetrating peptide-based delivery.. Expert opinion on drug delivery, 23(3), 495-515. https://doi.org/10.1080/17425247.2025.2587940